News Releases Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Overview Events & Presentations News Releases Financial Information SEC Filings Annual Reports Proxy Statement Tax Documents Stock Information Stock Quote & Chart Analyst Coverage Historical Price Lookup Corporate Governance Documents & Charters Management Committee Composition Investor FAQs Year None2021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 May 20, 2021 Luminex Corporation Declares Second Quarter Cash Dividend Mar 10, 2021 Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization Mar 09, 2021 Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference Mar 04, 2021 Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2 Feb 19, 2021 Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel Feb 08, 2021 Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results Feb 08, 2021 Luminex Corporation Declares First Quarter Cash Dividend Jan 27, 2021 Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 Jan 13, 2021 Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference Jan 12, 2021 Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue
Year None2021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 May 20, 2021 Luminex Corporation Declares Second Quarter Cash Dividend Mar 10, 2021 Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization Mar 09, 2021 Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference Mar 04, 2021 Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2 Feb 19, 2021 Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel Feb 08, 2021 Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results Feb 08, 2021 Luminex Corporation Declares First Quarter Cash Dividend Jan 27, 2021 Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 Jan 13, 2021 Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference Jan 12, 2021 Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue
Mar 10, 2021 Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Mar 04, 2021 Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2
Feb 19, 2021 Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel